Three members of the primary care roundtable discuss the doc fix and its importance in healthcare reform — but is it enough? Medscape Family Medicine
Category: News
Antidepressants Linked to Glaucoma in Elderly
A new study of more than 5000 patients found an increased risk for acute angle closure glaucoma after patients took antidepressants, especially mixed serotonergics/noradrenergics. Medscape Medical News
Bundling and Private Practice
Health and Human Services Secretary Sebelius answers Medscape readers’ questions about payment and other crucial issues addressed by healthcare reform. Medscape Business of Medicine
ORange Wavefront Aberrometer Proves Successful In Determining Refraction In Cataract Patients Who Previously Had LASIK Surgery
WaveTec Vision, the leader in wavefront-guided custom cataract™ surgery, announced today that its ORange® intraoperative wavefront aberrometer has been shown to be more predictable in determining refraction in the post-refractive eye, than any other…
New CNIB Survey Finds Many Canadians Less Than Well-Informed About Family History Of Glaucoma
According to a new CNIB survey released this week for World Glaucoma Week (March 7-13), few Canadians are as informed as they need to be about their family history of glaucoma, a serious and incurable eye condition that affects 250,000 Canadians…
Silence Therapeutics’ Partner Quark Pharmaceuticals Announces Results From Phase 2 PF-04523655 Study In Diabetic Macular Edema
Silence Therapeutics plc (AIM: SLN) (“Silence” or the “Company”) a leading global RNA interference (RNAi) therapeutics company, announces today that its partner, Quark Pharmaceuticals, has received results from a prospective randomized Phase 2 trial, t…
Silence Therapeutics’ Partner Quark Pharmaceuticals Announces Results From Phase 2 PF-04523655 Study In Diabetic Macular Edema
Silence Therapeutics plc (AIM: SLN) (“Silence” or the “Company”) a leading global RNA interference (RNAi) therapeutics company, announces today that its partner, Quark Pharmaceuticals, has received results from a prospective randomized Phase 2 trial, t…
Heidelberg Engineering Announces Expansion To New US Corporate Headquarters
Vista, CA – Due to continuing, rapid growth, Heidelberg Engineeringannounced plans to move its corporate US headquarters to the Carlsbad Research Center in Carlsbad, California at the beginning of April. The company will also move its service center to…
Heidelberg Engineering Announces Expansion To New US Corporate Headquarters
Vista, CA – Due to continuing, rapid growth, Heidelberg Engineeringannounced plans to move its corporate US headquarters to the Carlsbad Research Center in Carlsbad, California at the beginning of April. The company will also move its service center to…
Femtosecond-Guided LASIK Enhancement Has Minimal Trauma, Reduced Rate Of Epithelial Ingrowth
A new technique of LASIK enhancement using a femtosecond laser allows for easy flap re-lifting, minimal trauma and significantly reduced rate of epithelial ingrowth, according to one surgeon.
Femtosecond-Guided LASIK Enhancement Has Minimal Trauma, Reduced Rate Of Epithelial Ingrowth
A new technique of LASIK enhancement using a femtosecond laser allows for easy flap re-lifting, minimal trauma and significantly reduced rate of epithelial ingrowth, according to one surgeon.
Heidelberg Engineering Announces Expansion To New US Corporate Headquarters
Vista, CA – Due to continuing, rapid growth, Heidelberg Engineeringannounced plans to move its corporate US headquarters to the Carlsbad Research Center in Carlsbad, California at the beginning of April. The company will also move its service center to…
Retinal Surgery System And Lenses From Volk At ARVO
Mentor, Ohio – Volk Optical, the industry leader in aspheric optics, will be exhibiting at the Association for Research in Vision and Ophthalmology (ARVO), May 1 – 4 at the Broward County Convention Center (Fort Lauderdale, Florida), booth 509/511.
Retinal Surgery System And Lenses From Volk At ARVO
Mentor, Ohio – Volk Optical, the industry leader in aspheric optics, will be exhibiting at the Association for Research in Vision and Ophthalmology (ARVO), May 1 – 4 at the Broward County Convention Center (Fort Lauderdale, Florida), booth 509/511.
Efficacy and Safety of Anti-vascular Endothelial Growth Factor (VEGF) Therapy With Intravitreal Ranibizumab (Lucentis) for Naive Retinal Vein Occlusion: 1-year Follow-up
How safe and effective is intravitreal ranibizumab in treating retinal vein occlusion? The British Journal of Ophthalmology
In A Phase 2 Study PF-04523655 (RTP801I-14) Showed Improved Vision Over Standard Of Care In Patients With Diabetic Macular Edema At 12 Months
Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, today announced that it has received results from a prospective randomized Phase 2 trial, the DEGAS study. This study evaluated t…
In A Phase 2 Study PF-04523655 (RTP801I-14) Showed Improved Vision Over Standard Of Care In Patients With Diabetic Macular Edema At 12 Months
Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, today announced that it has received results from a prospective randomized Phase 2 trial, the DEGAS study. This study evaluated t…
Retina Implant to join with Wills Eye for U.S. artificial vision clinical trial
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced that they will partner with the Wills Eye Institute in Philadelphia as the lead U.S. clinical trial investigator site.
Dow Corning And The Centre For Vision In The Developing World Launch Children’s Vision Correction Initiative
Dow Corning, a global leader in silicon-based technology, and the Centre for Vision in the Developing World (CVDW) are jointly announcing a collaboration to create an innovative new way to help correct the vision of children in the developing world…
American Optometric Association Awards ACUVUE(R) ADVANCE(R) Plus Brand Contact Lenses With Seal Of Acceptance For UV Absorbing Contact Lenses
ACUVUE® ADVANCE® Plus Brand Contact Lenses became the sixth contact lens in the ACUVUE® Brand family of products to receive the Seal of Acceptance for Ultraviolet Absorbing Contact Lenses from the American Optometric Association’s (AOA) Commission o…